Evaluation of patient enrollment in oncology phase I clinical trials.
about
Barriers to study enrollment in patients with advanced cancer referred to a phase I clinical trials unit.The role of age on dose-limiting toxicities in phase I dose-escalation trials.Understanding how coping strategies and quality of life maintain hope in patients deliberating phase I trial participation.Access to clinical trials among oncology patients: results of a cross sectional surveyVariations in Unrealistic Optimism Between Acceptors and Decliners of Early Phase Cancer Trials.
P2860
Evaluation of patient enrollment in oncology phase I clinical trials.
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Evaluation of patient enrollment in oncology phase I clinical trials.
@ast
Evaluation of patient enrollment in oncology phase I clinical trials.
@en
Evaluation of patient enrollment in oncology phase I clinical trials.
@nl
type
label
Evaluation of patient enrollment in oncology phase I clinical trials.
@ast
Evaluation of patient enrollment in oncology phase I clinical trials.
@en
Evaluation of patient enrollment in oncology phase I clinical trials.
@nl
prefLabel
Evaluation of patient enrollment in oncology phase I clinical trials.
@ast
Evaluation of patient enrollment in oncology phase I clinical trials.
@en
Evaluation of patient enrollment in oncology phase I clinical trials.
@nl
P2093
P2860
P1433
P1476
Evaluation of patient enrollment in oncology phase I clinical trials
@en
P2093
Bronno van der Holt
Diane A J van der Biessen
Ferry A L M Eskens
Gaia Schiavon
Jaap Verweij
Maja J A de Jonge
Merlijn A Cranendonk
Ron H J Mathijssen
P2860
P304
P356
10.1634/THEONCOLOGIST.2012-0334
P50
P577
2013-02-21T00:00:00Z